Skip to main content

Table 1 General characteristics

From: Serial markers of coagulation and inflammation and the occurrence of clinical pulmonary thromboembolism in mechanically ventilated patients with SARS-CoV-2 infection; the prospective Maastricht intensive care COVID cohort

Variables Pulmonary Thromboembolism No Pulmonary Thromboembolism
Total (n = 31) CT-confirmed (n = 27) Suspected (n = 4) CT-confirmed (n = 8) p-value(Total vs No event)
Age, year, Mean (SD) 61.6 (12.9) 62.4 (13.4) 56.8 (9.0) 65.1 (11.7) 0.57
Male, (%) 27 (87.1) 23 (85.2) 4 (100.0) 6 (75.0) 0.58
Height, cm, Mean (SD) 177.2 (9.2) 176.0 (9.2) 185 (4.1) 171.0 (9.4) 0.10
Weight, kg, Mean (SD) 83.0 (11.0) 82.0 (10.4) 90.0 (14.1) 89.0 (19.1) 0.58
Body mass index, kg/m2, Mean (SD) 26.4 (2.8) 26.5 (2.8) 26.2 (3.7) 30.6 (6.9) 0.10
Admission location, by transfer from other hospital      0.41
 Emergency room, n (%) 12 (38.7) 11 (40.7) 1 (25.0) 2 (25.0)  
 Hospital ward, n (%) 11 (35.5) 9 (33.3) 2 (50.0) 5 (62.5)  
 Transfer from another ICU, n (%) 8 (25.8) 7 (25.9) 1 (25.0) 1 (12.5)  
Prior anti-coagulant use, yes (%) 1 (3.2) 1 (3.7) 0 (0) 0 (0) 1
Diabetes and complications, yes (%) 2 (6.5) 2 (7.4) 0 (0) 1 (12.5) 0.51
Presence of cardiovascular risk factors (hypertension, dyslipidaemia, smoking, obesity), yes (%) 14 (45.2) 11 (40.7) 3 (75.0) 2 (25.0) 0.43
APACHE- II score, points, Mean (SD) 15.7 (4.4) 15.4 (4.2) 17.5 (5.3) 19.0 (7.5) 0.13
  1. SD standard deviation; ICU Intensive Care Unit; APACHE Acute Physiology and Chronic Health Evaluation